Molecular landscape and targeted therapy of acute myeloid leukemia

For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by identifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Runxia, Yang, Xue, Wei, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225571/
https://www.ncbi.nlm.nih.gov/pubmed/30455953
http://dx.doi.org/10.1186/s40364-018-0146-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225571/
https://www.ncbi.nlm.nih.gov/pubmed/30455953
http://dx.doi.org/10.1186/s40364-018-0146-7

Ejemplares similares